Skip to Content

Cresco Labs Inc CRLBF

Morningstar Rating
$2.00 −0.10 (4.76%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CRLBF is trading at a 41% discount.
Price
$2.00
Fair Value
$2.77
Uncertainty
Extreme
1-Star Price
$3.88
5-Star Price
$4.58
Economic Moat
Zlsb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRLBF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.10
Day Range
$1.992.19
52-Week Range
$1.002.77
Bid/Ask
$2.00 / $2.05
Market Cap
$679.42 Mil
Volume/Avg
374,479 / 988,383

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.86
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
2,760

Comparables

Valuation

Metric
CRLBF
VRNO
CURA
Price/Earnings (Normalized)
Price/Book Value
1.381.543.66
Price/Sales
0.861.992.77
Price/Cash Flow
15.3117.0065.35
Price/Earnings
CRLBF
VRNO
CURA

Financial Strength

Metric
CRLBF
VRNO
CURA
Quick Ratio
0.780.520.31
Current Ratio
1.390.960.85
Interest Coverage
−1.361.46−0.24
Quick Ratio
CRLBF
VRNO
CURA

Profitability

Metric
CRLBF
VRNO
CURA
Return on Assets (Normalized)
−3.12%−2.28%−3.72%
Return on Equity (Normalized)
−8.02%−4.10%−10.45%
Return on Invested Capital (Normalized)
−0.11%−0.53%−2.20%
Return on Assets
CRLBF
VRNO
CURA
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AKpqgyxrfRhyhw$70.0 Bil
MKKGY
Merck KGaA ADRWrmtgzvhzRrmngt$67.6 Bil
HLN
Haleon PLC ADRXdyyrwfbtMhmv$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRLtdlmmbqhShq$14.3 Bil
VTRS
Viatris IncNtmpggmgzHkr$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHydtymzcsHhzty$11.9 Bil
CTLT
Catalent IncPvmxhqsWzgrxc$10.0 Bil
PRGO
Perrigo Co PLCZwbmhjhcQcgh$4.1 Bil
CURLF
Curaleaf Holdings IncGtvmvxmZkw$3.6 Bil
PBH
Prestige Consumer Healthcare IncZbzmxypsHkwntt$3.4 Bil

Sponsor Center